1. Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance
   V Chell et al, 2013, Oncogene CrossRef
2. Forkhead Box M1 (FoxM1) Gene Is a New STAT3 Transcriptional Factor Target and Is Essential for Proliferation, Survival and DNA Repair of K562 Cell Line
   André L. Mencalha et al, 2012, PLoS ONE CrossRef
3. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
   Hamid Ali Nagi Al-Jamal et al, 2015, BMC Cancer CrossRef
4. Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX
   Jingjing Wu et al, 2019, Molecular Medicine Reports CrossRef